LAPROPHAN, a Mediterrania Capital Partners' portfolio company, and a major player in the pharmaceutical sector in Africa and the Middle East, has announced the acquisition* of a majority stake in Botanic Pharma, a company specialising in natural food supplements.

With the integration of Botanic Pharma, Laprophan strengthens and consolidates its position in the healthcare sector. This expansion will enable the company to broaden its product portfolio in the European and African markets while increasing its capacity to export innovative and high-quality healthcare products.

The acquisition also supports Laprophan’s ambition to become a major player in the rapidly expanding global food supplements sector. Mediterrania wishes Laprophan continued success in its mission to improve the quality of life for millions of people through high-quality medicines and healthcare products.

*Subject to regulatory approvals.

Fuente: Mediterrania Capital Partners

https://www.mcapitalp.com/category/portfolio-news/
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Xcalibur Smart Mapping strengthens its g...

by MCH Private Equity

​Xcalibur Smart Mapping, recognised as the global leader in airborne...

Photos Stream